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Facing the many host defense mechanisms 
at different stages of the infection, a patho-
gen needs to employ corresponding arsenals 
either to hijack host cellular processes for its 
own use or to thwart the attacks from the 
host. For numerous bacterial pathogens, one 
of the effective weapons is effector protein. 
Type IV protein secretion systems are asso-
ciated with the virulence of many impor-
tant pathogens such as Helicobacter pylori, 
Bartenella pertussis, Brucella spp., Coxiella 
burnetii,  and  Legionella  pneumophila 
(Backert and Meyer, 2006). Although the 
structures of these transporters appear sim-
ilar, their protein substrates differ drastically 
not only in functions but also in abundance. 
For example, despite extensive efforts, CagA 
is the only effector identified for the Cag 
system of H. pylori (Hatakeyama, 2008). On 
the other hand, there are at least 274 experi-
mentally confirmed protein substrates of 
the L. pneumophila Dot/Icm system (Zhu 
et al., 2011). This count is close to 10% of 
the predicted genes in the L. pneumophila 
genome (Cazalet et al., 2004; Chien et al., 
2004; Schroeder et al., 2010), making the 
Dot/Icm system arguably the most prolific 
protein transporter in term of the number of 
translocated substrates. Similar to effectors 
of other types of secretion systems, Dot/Icm 
substrates function to target various host 
cellular processes, such as vesicle trafficking, 
cell death, ubiquitination, lipid metabolism, 
and innate immunity, thus allowing the bio-
genesis of an intracellular niche permissive 
for bacterial replication (Isberg et al., 2009; 
Hubber and Roy, 2010).
To cope with the dynamic response from 
the host, bacterial pathogens can employ 
several strategies to achieve temporal regu-
lation of the activity of their virulence fac-
tors. The most commonly used mechanism 
is to regulate expression of virulence factors 
at the transcriptional level in response to 
environmental  cues  present  during  dif-
ferent  phases  of  infection.  For  example, 
many Legionella effector genes are induced 
when bacteria enter the post-exponential 
phase and are ready to infect (Bruggemann 
et al., 2006). The second is to control the 
translocation efficiency of effectors at post-
translational level, which is exemplified by 
small RNA-mediated regulation of effec-
tor  transfer  in  Salmonella  typhimurium 
(Padalon-Brauch et al., 2008). The third 
is to code for effectors capable of causing 
opposite cell biological effects to neutralize 
or reverse the effects caused by other effec-
tors. In S. typhimurium, bacterial entry is 
induced  by  SopE,  a  guanine  nucleotide 
exchange factor (GEF) for the Rho family 
of small GTPases, an activity that is antag-
onized by the GTPase activation protein 
(GAP) SopE. In this scenario, temporal con-
trol is achieved by the inherent differences 
in the sensitivity of these two proteins to 
host proteasome degradation (Kubori and 
Galan,  2003).  Similarly,  L.  pneumophila 
reverses the SidM/DrrA-mediated activa-
tion of the small GTPase Rab1 by the GAP 
protein LepB (Ingmundson et al., 2007). 
However, the mechanism underlying the 
temporal control remains elusive. Third, the 
pathogens can inhibit pathways triggered by 
themselves. For example, as a result of apop-
tosis induced by L. pneumophila challenge, 
infected cells contains active caspases 3 and 
7, but the activity of these enzymes presum-
ably can be inhibited by IAPs induced by 
the bacterium itself (Abu-Zant et al., 2005, 
2007;  Losick  and  Isberg,  2006;  Nogueira 
et al., 2009). Unfortunately, the bacterial 
proteins  involved  in  such  manipulation 
remain unknown as does the mechanism 
underlying the temporal regulation.
Almost all characterized virulence factors 
exert their effects by targeting one or more 
host molecules. The discovery by Kubori 
et al. (2010) extended the roles of bacterial 
effectors into a completely new domain: 
direct regulation of the function of other 
effectors, in this particular case, by target-
ing a different effector protein for protea-
some degradation. LubX is a U-box-type E3 
  ubiquitin ligase that was previously found 
to target the host kinase Clk1 (Kubori et al., 
2008). In this new study, the authors reported 
that  LubX  polyubiquitinates  the  effector 
SidH and targets it for degradation (Kubori 
et al., 2010). Moreover, their data showed 
that in a fruit fly infection model, deletion 
of lubX caused a hyper-lethality phenotype 
and reduced bacterial replication. Thus, this 
discovery  established  a  new  mechanism 
used by a bacterial pathogen to temporally 
control the activity of its virulence factors. 
Their results also substantiated some earlier 
observations on L. pneumophila infection. 
First, they showed that LubX is expressed 
and  translocated  by  the  Dot/Icm  system 
only until after the initial phase of infec-
tion has been established, peaking at 10 h 
post infection (Kubori et al., 2008, 2010), 
which is in line with the observation that the 
Dot/Icm system is active for at least 8 h after 
bacterial internalization (Liu et al., 2008). 
Second, targeting of SidH did not occur 
in the initial phase of infection, implying 
that SidH is important in the early phase 
of infection and becomes unnecessary or 
even detrimental to further development of 
the bacterial phagosome as infection pro-
ceeds. Such prediction is consistent with 
the potential role of SidH in inhibition of 
host cell death (Laguna et al., 2006), because 
continued arrest of apoptosis presumably 
is  counterproductive  when  the  infection 
comes to a close.
This  study  also  provided  an  explana-
tion to one of the perplexing questions in 
the study of L. pneumophila pathogenesis: 
Why does this bacterium code for so many 
effectors? At least two models can be used to 
explain this phenomenon. The first is that 
there is a tremendous functional redundancy 
among effectors targeting a particular host 
cellular process. This model is supported 
by the fact that mutations eliminating one 
single effector gene rarely caused defects in 
intracellular bacterial growth (Ensminger 
and Isberg, 2009). Second, these effectors Frontiers in Microbiology  |  Cellular and Infection Microbiology    February 2011  | Volume 2  | Article 31  |  2
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may be necessary for successful coloniza-
tion  of  the  taxonomically  diverse  proto-
zoan hosts encountered by L. pneumophila 
in the environment. The study by Nagai 
and colleagues added a novel dimension 
of  targets  regulated  by  L.  pneumophila 
virulence factors.
Given  the  complexity  of  the  interac-
tions between L. pneumophila and its hosts, 
it will not be surprising to identify more 
metaeffectors with modes of action differ-
ent from that of LubX in future study. It is 
possible that inhibition of effector activity 
by a second effector can be achieved by post-
translational modifications. An effector can 
directly reverse the modification made by 
another  effector  on  its  target  molecule. 
For example, such regulation conceivably 
can be achieved by a pair of effectors with 
kinase and phosphatase activity, respectively. 
Alternatively, one effector can directly mod-
ify  another  effector  at  post-translational 
level to activate or inactivate its function. 
As  novel  post-translational  modifications 
such as AMPylation (Roy and Mukherjee, 
2009; Muller et al., 2010) and farnesylation 
(Ivanov et al., 2010; Price et al., 2010) con-
tinued to be identified in Legionella effectors, 
it will be interesting to know whether these 
modifications are subjected to effector-me-
diated regulation. Although the existence of 
these regulatory mechanisms in the control 
of L. pneumophila effector activity is uncer-
tain, it is certain that more excitement will be 
generated in our continuing study of these 
several hundreds interesting proteins.
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